A six-level conceptual cascade framework, linking metabolic vulnerability, stress-hormone activation, exogenous substrate load, enteroinsular axis dysfunction, inflammation-mediated insulin resistance, and microbiota dysbiosis is proposed, linking metabolic vulnerability, stress-hormone activation, exogenous substrate load, and microbiota dysbiosis.
Abstract
Background Hyperglycemia is a common complication in critically ill patients receiving enteral nutrition (EN). This review synthesizes evidence on its mechanisms, epidemiology, clinical implications, and nursing management to support precision glycemic care. Methods A systematic literature search identified 45 eligible studies, including randomized trials, retrospective studies, reviews, guidelines, and expert consensus statements. Given the lack of a universally accepted definition, enteral nutrition-related hyperglycemia was pragmatically defined as blood glucose ≥7.8 mmol/L occurring within 24−72 h after initiation of enteral nutrition. Results Reported incidence varies widely, from approximately 30−47% in general ICU populations to 60−80% following cardiac surgery, reflecting differences in definitions, patient characteristics, timing, and nutritional protocols. Based on thematic integration of existing evidence, we propose a six-level conceptual cascade framework, linking metabolic vulnerability, stress-hormone activation, exogenous substrate load, enteroinsular axis dysfunction, inflammation-mediated insulin resistance, and microbiota dysbiosis. Corresponding nursing strategies include diabetes-specific formulas, optimized feeding regimens, continuous glucose monitoring, and individualized insulin protocols within multidisciplinary care. These strategies may improve glycemic control; however, evidence for clinical outcome benefits remains limited and heterogeneous. Conclusion Further prospective studies are needed to validate the model and refine precision nursing strategies.
Introduction Enteral nutrition interruption (ENI) is common in critically ill patients and may compromise nutritional delivery, but its prevalence, causes, and clinical consequences remain uncertain. This systematic review and meta-analysis synthesized evidence on ENI prevalence, contributing factors, clinical outcomes...
Xiao-Jing Guo, Li-Bing Jiang, Shou-Yin Jiang et al.· Frontiers in Nutrition· 0 citations
Children with cancer who require pediatric intensive care encounter overlapping metabolic insults from cancer biology, anticancer treatment, and critical illness. These insults may produce a dynamic malnutrition phenotype characterized by impaired intake or absorption, rapid lean-mass loss, micronutrient and electrolyt...
Pei-Yu Huang, Zhiyi Deng· Cancer Plus· 0 citations
The therapeutic potential of innovative enteral formulas based on the P4 protein complex (a combination of dairy and non-coagulating plant proteins) successfully overcomes gastrointestinal intolerance to nutritional support in critically ill patients.
I. Pasechnik, T. V. Novikova· Russian Journal of Anesthesi...· 0 citations
Background: Nutritional support in critically ill patients remains one of the most debated aspects of intensive care medicine. Although international guidelines have long recommended early nutritional support with progressive protein delivery, recent clinical evidence has questioned the benefit of aggressive early calo...
M. Stoian, A. Stoian, C. Bănescu et al.· Nutrients· 0 citations
Ass associations between an evidence-based feeding protocol and clinical outcomes differed across age groups, and potential age-related heterogeneity in treatment response is suggested, which requires confirmation in future prospective studies.
Qiu-Hui Wang, Jin Ke, Yi-Zhe Chen et al.· Journal of Intensive Care· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.